ERp29 induces breast cancer cell growth arrest and survival through modulation of activation of p38 and upregulation of ER stress protein p58 IPK

Laboratory Investigation

Volumn 92, Issue 2, 2012, Pages 200-213

  Gao, Danmei ^a   Bambang, I Fon ^a   Putti, Thomas C ^a   Lee, Yuan Kun ^a   Richardson, Des R ^b   Zhang, Daohai ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

drug resistance; ER stress; ERp29; growth arrest; p38 ; p58 IPK

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; BETA1 INTEGRIN; CASPASE 3; CYCLIN D2; ENDOPLASMIC RETICULUM PROTEIN 29; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INITIATION FACTOR 2ALPHA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; PROTEIN P15; PROTEIN P21; PROTEIN P58; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GENE SILENCING; HEAT-SHOCK PROTEINS; HSP40 HEAT-SHOCK PROTEINS; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RNA INTERFERENCE; UP-REGULATION;

EID: 84863062264     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.163     Document Type: Article

References (50)

1. Ellgaard L, Ruddock LW. The human protein disulphide isomerase family: substrate interaction and function properties. EMBO Rep 2005;8:28-32. (Pubitemid 41710070)
2. Mkrtchian S, Sandalova T. ERp29, an unusual redox-inactive member of the thioredoxin family. Antioxid Redox Signal 2006;8:325-337. (Pubitemid 43741303)
3. Rainey-Barger EK, Mkrtchian S, Tsai B. The C-terminal domain of ERp29 mediates polyomavirus binding, unfolding, and infection. J Virol 2009;83:1483-1491.
4. Rainey-Barger EK, Mkrtchian S, Tsai B. Dimerization of ERp29, a PDI-like protein, is essential for its diverse functions. Mol Biol Cell 2007;18:1253-1260. (Pubitemid 46626620)
5. Das S, Smith TD, Sarma JD, et al. ERp29 restricts connexin43 oligomerization in the endoplasmic reticulum. Mol Biol Cell 2009;20:2593-2604.
6. Bambang IF, Xu S, Zhou J, et al. Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells. Lab Invest 2009;89:1229-1242.
7. Qi L, Wu P, Zhang X, et al. Inhibiting ERp29 expression enhances radiosensitivity in human nasopharyngeal carcinoma cell lines. Med Oncol 2011; advance online publication, 11 April 2011; doi: 10.1007/s12032-011-9929-5.
8. Farmaki E, Mkrtchian S, Papazian I, et al. ERp29 regulates response to doxorubicin by a PERK-mediated mechanism. Biochim Biophys Acta 2011;1813:1165-1171.
9. Zhang D, Putti TC. Over-expression of ERp29 attenuates doxorubicininduced cell apoptosis through up-regulation of Hsp27 in breast cancer cells. Exp Cell Res 2010;316:3522-3531.
10. Yu W, Kim J, Ossowski L. Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy. J Cell Biol 1997;137:767-777. (Pubitemid 27200676)
11. Ranganathan AC, Adam AP, Aguirre-Ghiso JA. Opposing roles of mitogenic and stress signaling pathways in the induction of cancer dormancy. Cell Cycle 2006;5:1799-1807. (Pubitemid 44435322)
12. Allgayer H, Aguirre-Ghiso JA. The urokinase receptor (u-PAR)-a link between tumor cell dormancy and minimal residual disease in bone marrow? APMIS 2008 116 602-614.
13. Aguirre-Ghiso JA, Estrada Y, Liu D, et al. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 2003;63:1684-1958.
14. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007;7:834-846. (Pubitemid 350006258)
15. Aguirre Ghiso JA, Kovalski K, Ossowski L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 1999;147:89-104.
16. Aguirre-Ghiso JA, Liu D, Mignatti A, et al. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell 2001;12:863-879. (Pubitemid 33051984)
17. Schewe DM, Aguirre-Ghiso JA. ATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo. Proc Natl Acad Sci USA 2008;105:10519-10524.
18. Ranganathan AC, Adam AP, Zhang L, et al. Tumor cell dormancy induced by p38SAPK and ER-stress signaling: an adaptive advantage for metastatic cells? Cancer Biol Ther 2006 729-735. (Pubitemid 44775124)
19. Welihinda AA, Tirasophon W, Kaufman RJ. The cellular response to protein misfolding in the endoplasmic reticulum. Gene Exp 1999;7:293-300. (Pubitemid 29372073)
20. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007;8:519-529. (Pubitemid 46985379)
21. Wang G, Yang ZQ, Zhang K. Endoplasmic reticulum stress response in cancer: molecular mechanism and therapeutic potential. Am J Transl Res 2010;2:65-74.
22. Rutkowski DT, Kaufman RJ. A trip to the ER: coping with stress. Trends Cell Biol 2004;14:20-28. (Pubitemid 38076857)
23. Brewer JW, Diehl JA. PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proc Natl Acad Sci USA 2000;97:12625-12630.
24. Ranganathan AC, Zhang L, Adam AP, et al. Functional coupling of p38- induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res 2006;66:1702-1711. (Pubitemid 43259955)
25. Adam AP, George A, Schewe D, et al. Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence. Cancer Res 2009;69:5664-5672.
26. Wong LL, Chang CF, Koay ES, et al. Tyrosine phosphorylation of PP2A is regulated by HER-2 signalling and correlates with breast cancer progression. Int J Oncol 2009;34:1291-1301.
27. Leber TM, Frances R, Balkwill FR. Zymography: a single-step staining method for quantitation of proteolytic activity on substrate gels. Anal Biochem 1997;249:24-28. (Pubitemid 27251938)
28. Ahmad A, Kong D, Wang Z, et al. Down-regulation of uPA and uPAR by 3,30-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells. J Cell Biochem 2009;108:916-925.
29. Kunigal S, Lakka SS, Gondi CS, et al. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease- 9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int J Cancer 2007;121:2307-2316. (Pubitemid 47585614)
30. Hsu T, Trojanowska M, Watson DK. Ets proteins in biological control and cancer. J Cell Biochem 2004;91:896-890.
31. Barkan D, Kleinman H, Simmons JL, et al. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 2008;68:6241-6250.
32. Aguirre Ghiso JA. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene 2002;21:2513-2524. (Pubitemid 34438104)
33. Ahmed N, Oliva K, Wang Y, et al. Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells. Br J Cancer 2003;89:374-384. (Pubitemid 36976329)
34. Loesch M, Zhi HY, Hou SW, et al. p38gamma MAPK cooperates with c- Jun in trans-activating matrix metalloproteinase 9. J Biol Chem 2010;285:15149-15158.
35. Kim MS, Lee EJ, Kim HR, et al. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res 2003;63:5454-5461.
36. Lee AH, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 2003;23:7448-7459. (Pubitemid 37271447)
37. van Huizen R, Martindale JL, Gorospe M, et al. P58IPK, a novel endoplasmic reticulum stress-inducible protein and potential negative regulator of eIF2alpha signaling. J Biol Chem 2003;278:15558-15564. (Pubitemid 36799663)
38. Harding HP, Novoa I, Zhang Y, et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 2000;6:1099-1108.
39. Bulavin DV, Fornace Jr AJ. p38 MAP kinase's emerging role as a tumor suppressor. Adv Cancer Res 2004;92:95-118. (Pubitemid 39458114)
40. Ferreiro I, Joaquin M, Islam A, et al. Whole genome analysis of p38 SAPK-mediated gene expression upon stress. BMC Genomics 2010;11:144.
41. Hümbelin M, Safer B, Chiorini JA, et al. Isolation and characterization of the promoter and flanking regions of the gene encoding the human protein-synthesis-initiation factor 2 alpha. Gene 1989;81:315-324. (Pubitemid 19231579)
42. Verfaillie T, Salazar M, Velasco G, et al. Linking ER stress to autophagy: potential implications for cancer therapy. Int J Cell Biol 2010;2010:930509.
43. Harding HP, Zhang Y, Zeng H, et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 2003;11:619-633. (Pubitemid 36385118)
44. Lee TG, Tomita J, Hovanessian AG, et al. Characterization and regulation of the 58 000-dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase. J Biol Chem 1992;267:14238-14243.
45. Polyak SJ, Tang N, Wambach M, et al. The P58 cellular inhibitor complexes with the interferon-induced, double-stranded RNAdependent protein kinase, PKR, to regulate its autophosphorylation and activity. J Biol Chem 1996;271:1702-1707.
46. Yan W, Frank CL, Korth MJ, et al. Control of PERK eIF2alpha kinase activity by the endoplasmic reticulum stress-induced molecular chaperone P58IPK. Proc Natl Acad Sci USA 2002;99:15920-15925. (Pubitemid 35462724)
47. Srivastava SP, Kumar KU, Kaufman RJ. Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. J Biol Chem 1998;273:2416-2423. (Pubitemid 28069300)
48. Novoa I, Zeng H, Harding HP, et al. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol 2001;153:1011-1022.
49. Yoshida H, Matsui T, Yamamoto A, et al. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 2001;107:881-891. (Pubitemid 34084979)
50. Naumov GN, Townson JL, MacDonald IC, et al. Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat 2003;82:199-206. (Pubitemid 37521976)